Hydrogel Spacer
FDA adverse event reports and recall history for hydrogel spacer (product code OVB), from the public MAUDE corpus and the live FDA recall database.
- Total reports
- 2,087
- Deaths
- 9
- Injuries
- 757
- Malfunctions
- 1,321
Reports per year
Source: FDA adverse event reports by year received, 2016–2026. Reporting paused twice in 2026 during FDA reporting-system changes and has since resumed.
Recent recalls
- Open, ClassifiedLabeling design
SpaceOAR System, UPN SO-1010, SO-2101, SO-3101, and SO-4101. Used to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer to reduce the radiation dose delivered to the anterior rectum.
Users need to be aware that embolism is a possible adverse event associated with hydrogel misplacements. Updated IFU provides new procedural instructions, warnings and precautions that describe steps to verify correct placement of the hydrogel following implantation, as well as technique recommendations for the proper placement of SpaceOAR and SpaceOAR Vue.
- Open, ClassifiedLabeling design
SpaceOAR Vue System, UPN SV-1010 and SV-2101. Used to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer to reduce the radiation dose delivered to the anterior rectum.
Users need to be aware that embolism is a possible adverse event associated with hydrogel misplacements. Updated IFU provides new procedural instructions, warnings and precautions that describe steps to verify correct placement of the hydrogel following implantation, as well as technique recommendations for the proper placement of SpaceOAR and SpaceOAR Vue.
Monitor hydrogel spacer automatically
DeviceWatch watches FDA adverse events and recalls for the products you care about, summarizes clinical narratives with AI and alerts you when a safety signal emerges.